In HNSCC, a high level of EZH2 or MYC has been associated with tumorigenesis, recurrence, lymph node metastasis, and poor prognosis.[42] However, the precise cooperative roles of these oncoproteins in HNSCC progression remain unclear. The gene discussed is MYC; the disease is head and neck squamous cell carcinoma.